Philip Johnson

12PUBLICATIONS
20CO-AUTHORS
Epidemiological modellingPredictive and prognostic markersHaematological tumoursDisease surveillanceMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 25, 2026
Predicting the Risk of Decompensation in Patients With Cirrhosis: A Validated Machine Learning Approach.

Philip J Johnson, Anton Kalyuzhnyy, Arturas Grauslys

|Jul 16, 2025
Intrapatient Variation in Response to Systemic Therapy in Advanced Hepatocellular Carcinoma.

Philip J Johnson, Ellen L Boswell

|Nov 08, 2024
Progression of chronic liver disease to hepatocellular carcinoma: implications for surveillance and management.

Philip J Johnson, Anton Kalyuzhnyy, Ellen Boswell

|Feb 22, 2023
'Potentially curative therapies' for hepatocellular carcinoma: how many patients can actually be cured?

Alessandro Cucchetti, Omar Elshaarawy, Guohong Han

|Jul 07, 2022
Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify.

Philip J Johnson, Hamish Innes, David M Hughes

Pageof 2